Difficulty: Medium
Average Score: 84%
Practice
A 39-year-old man with HIV disease and active tuberculosis is hospitalized for therapy. He currently takes a protease inhibitor. He complains of cough, dyspnea, and chest pressure. Which of the following is the best treatment adjunct for this patient?
Correct answer
B
Rationale
In this case, the best treatment adjunct for the 39-year-old man with HIV disease, active tuberculosis, and currently taking a protease inhibitor who presents with symptoms of cough, dyspnea, and chest pressure is option B) Rifabutin.
Rifabutin is the preferred choice in this scenario because it is a rifamycin antibiotic that is less likely to interact with protease inhibitors compared to Rifampin (option C). Rifampin is known to significantly reduce the levels of protease inhibitors in the blood, which can lead to treatment failure.
Prednisone (option A) is a corticosteroid that may be used in specific cases like managing inflammation in tuberculosis, but it is not the best choice as an adjunct treatment in this situation.
Ribavirin (option D) is an antiviral medication primarily used to treat respiratory syncytial virus (RSV) and hepatitis C, and it is not indicated for the current patient's condition.
Educationally, understanding drug interactions and selecting the most appropriate adjunct treatment considering a patient's comorbidities, current medications, and specific condition is crucial in providing effective and safe care. This case highlights the importance of pharmacological knowledge in managing complex medical cases, especially in patients with multiple concurrent health issues like HIV, tuberculosis, and drug-drug interactions.
Rifabutin is the preferred choice in this scenario because it is a rifamycin antibiotic that is less likely to interact with protease inhibitors compared to Rifampin (option C). Rifampin is known to significantly reduce the levels of protease inhibitors in the blood, which can lead to treatment failure.
Prednisone (option A) is a corticosteroid that may be used in specific cases like managing inflammation in tuberculosis, but it is not the best choice as an adjunct treatment in this situation.
Ribavirin (option D) is an antiviral medication primarily used to treat respiratory syncytial virus (RSV) and hepatitis C, and it is not indicated for the current patient's condition.
Educationally, understanding drug interactions and selecting the most appropriate adjunct treatment considering a patient's comorbidities, current medications, and specific condition is crucial in providing effective and safe care. This case highlights the importance of pharmacological knowledge in managing complex medical cases, especially in patients with multiple concurrent health issues like HIV, tuberculosis, and drug-drug interactions.